Steve J. Cramer

1.9k total citations
31 papers, 1.5k citations indexed

About

Steve J. Cramer is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Steve J. Cramer has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 17 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Steve J. Cramer's work include Virus-based gene therapy research (19 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and CAR-T cell therapy research (6 papers). Steve J. Cramer is often cited by papers focused on Virus-based gene therapy research (19 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and CAR-T cell therapy research (6 papers). Steve J. Cramer collaborates with scholars based in Netherlands, United States and Belgium. Steve J. Cramer's co-authors include Rob C. Hoeben, Frits J. Fallaux, H. van Ormondt, Alex J. van der Eb, Onno Kranenburg, Ada Houweling, Diana J.M. van den Wollenberg, Micheline Giphart-Gassler, Pieter van de Putte and Dinko Valerio and has published in prestigious journals such as Nature, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Steve J. Cramer

31 papers receiving 1.5k citations

Peers

Countries citing papers authored by Steve J. Cramer

Since Specialization

Citations

This map shows the geographic impact of Steve J. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve J. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve J. Cramer more than expected).

Fields of papers citing papers by Steve J. Cramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve J. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve J. Cramer. The network helps show where Steve J. Cramer may publish in the future.

Co-authorship network of co-authors of Steve J. Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Steve J. Cramer. A scholar is included among the top collaborators of Steve J. Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve J. Cramer. Steve J. Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small RNA sequencing reveals snoRNAs and piRNA-019825 as novel players in diabetic kidney disease 2024 ·Endocrine ·Leen M. ‘t Hart, (unknown), (unknown), (unknown), Marieke T. Blom, Steve J. Cramer, Roel Bijkerk, Joline W. J. Beulens, Roderick C. Slieker	7
2	Introduction of a Geminin mScarlet Reporter into H2B-mTurq2 hiPSCs for Live-cell Imaging of Proliferation and Cell Cycling 2023 ·Stem Cell Research ·(unknown), Steve J. Cramer, Christian Freund, Christine L. Mummery, (unknown), Harald Mikkers	1
3	Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates 2021 ·Human Gene Therapy ·(unknown), (unknown), Steve J. Cramer, Diana J.M. van den Wollenberg, Marten Hornsveld, Martine L.M. Lamfers, Gabri van der Pluijm, Rob C. Hoeben	11
4	Generation of LUMCi041-A-2: Equipping a PAX3 reporter iPSC line with doxycycline inducible H2B-mTurquoise2 for live cell imaging 2021 ·Stem Cell Research ·(unknown), Umesh Chaudhari, Steve J. Cramer, Christian Freund, Christine L. Mummery, Adrian Ranga, Olivier Pourquié, Harald Mikkers	1
5	NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice—A Novel in Vivo Imaging Platform 2020 ·International Journal of Molecular Sciences ·(unknown), Giorgia Zambito, (unknown), Steve J. Cramer, Rob C. Hoeben, Clemens W.G.M. Löwik, Joel R. Walker, Thomas A. Kirkland, Thomas P. Smith, Wytske M. van Weerden, Jeroen de Vrij, Laura Mezzanotte	38
6	Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene 2018 ·Gene Therapy ·(unknown), (unknown), Steve J. Cramer, Rob C. Hoeben, Diana J.M. van den Wollenberg	4
7	Optimizing reporter constructs for in vivo bioluminescence imaging of interferon-γ stimulated mesenchymal stromal cells 2014 ·Experimental Hematology ·Jorge Pérez, Françoise Carlotti, Martijn J. W. E. Rabelink, Steve J. Cramer, Rob C. Hoeben, Willem E. Fibbe, Melissa van Pel	6
8	Adenoviral Vectors Stimulate Glucagon Transcription in Human Mesenchymal Stem Cells Expressing Pancreatic Transcription Factors 2012 ·PLoS ONE ·Arnaud Zaldumbide, Françoise Carlotti, Manuel A.F.V. Gonçalves, Shoshan Knaän‐Shanzer, Steve J. Cramer, Bart O. Roep, Emmanuel J. H. J. Wiertz, Rob C. Hoeben	11
9	Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A 2012 ·PLoS ONE ·Diana J.M. van den Wollenberg, (unknown), S K van den Hengel, Steve J. Cramer, Raoul J. de Groot, Rob C. Hoeben	45
10	Directed adenovirus evolution using engineered mutator viral polymerases 2010 ·Nucleic Acids Research ·Taco G. Uil, Jort Vellinga, Jeroen de Vrij, S K van den Hengel, Martijn J. W. E. Rabelink, Steve J. Cramer, Julia J.M. Eekels, Yavuz Ariyürek, Michiel van Galen, Rob C. Hoeben	26
11	A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator 2010 ·Biotechnology Letters ·Arnaud Zaldumbide, (unknown), Steve J. Cramer, Martijn J. W. E. Rabelink, Joost Verhaagen, Rob C. Hoeben	15
12	A lentiviral vector‐based adenovirus fiber‐pseudotyping approach for expedited functional assessment of candidate retargeted fibers 2009 ·The Journal of Gene Medicine ·Taco G. Uil, Jeroen de Vrij, Jort Vellinga, Martijn J. W. E. Rabelink, Steve J. Cramer, (unknown), (unknown), Maria K. Magnusson, Leif Lindholm, Pierre Boulanger, Rob C. Hoeben	9
13	Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX 2008 ·Gene Therapy ·Jeroen de Vrij, Taco G. Uil, S K van den Hengel, Steve J. Cramer, Danijela Koppers‐Lalic, Marieke C. Verweij, Emmanuel J. H. J. Wiertz, Jort Vellinga, Ralph A. Willemsen, Rob C. Hoeben	19
14	A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting 2008 ·Gene Therapy ·Diana J.M. van den Wollenberg, S K van den Hengel, (unknown), Steve J. Cramer, Onno Kranenburg, Rob C. Hoeben	32
15	Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells 2000 ·Gene Therapy ·Sacha B. Geutskens, M.M. van der Eb, Arianne C. Plomp, Liesbeth E. Jonges, Steve J. Cramer, N. Geeske Ensink, Peter J.K. Kuppen, Rob C. Hoeben	49
16	Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation 1999 ·Gene Therapy ·Frederik H.E. Schagen, Anne C.E. Moor, (unknown), Steve J. Cramer, H. van Ormondt, A.J. van der Eb, T.M.A.R. Dubbelman, Rob C. Hoeben	44
17	New Helper Cells and Matched Early Region 1-Deleted Adenovirus Vectors Prevent Generation of Replication-Competent Adenoviruses 1998 ·Human Gene Therapy ·Frits J. Fallaux, A. Bout, Ietje van der Velde, Diana J.M. van den Wollenberg, Kathleen Hehir, (unknown), (unknown), Steve J. Cramer, H. van Ormondt, Alex J. van der Eb, Dinko Valerio, Rob C. Hoeben	369
18	Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral Vectors 1996 ·Human Gene Therapy ·Frits J. Fallaux, Onno Kranenburg, Steve J. Cramer, Ada Houweling, H. van Ormondt, Rob C. Hoeben, Alex J. van der Eb	457
19	Invertible DNA determines host specificity of bacteriophage Mu 1980 ·Nature ·Pieter van de Putte, Steve J. Cramer, Micheline Giphart-Gassler	130
20	The facilitation of tumour growth in the lung by cyclophosphamide in artificial and spontaneous metastases models 1979 ·European Journal of Cancer (1965) ·J. de Ruiter, Steve J. Cramer, (unknown), L. M. van Putten	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact